3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase EARLY_PHASE1
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Thoracic
1
Conditions
Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Propofol
9
Sevoflurane
7
Rituximab
7
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Trastuzumab
5
Specimen Handling
5
Enoxaparin
5
Carboplatin
5
Bevacizumab
5
Nivolumab
4
Capecitabine
4
Bupivacaine
4
trametinib
3
pirtobrutinib
3
dabrafenib
3
atezolizumab
3
apixaban
3
Lenalidomide
3
Indocyanine Green
3
Gemcitabine
3
Docetaxel
3
Cyclophosphamide
3
zanubrutinib
2
venetoclax
2
trastuzumab deruxtecan
2
ribociclib
2
polyethylene glycol 3350
2
pertuzumab
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Cobicistat
×
Clear all
NCT05748093
2024-08-09
OSIBOOST 2
Maastricht University Medical Center
Phase 4
Recruiting
60 enrolled
NCT05078671
2024-06-12
PROACTIVE
Radboud University Medical Center
Phase 4
Recruiting
160 enrolled